Clinical Trial Update: Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer [NA]

View source ↗

Summary

This document reports a clinical trial update on the safety of concurrent radiotherapy and a novel systemic therapy for breast cancer, with the study currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CDK4/6 inhibitor
• Immune checkpoint inhibitor
• PARP inhibitor
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Breast Cancer, Familial Male, Radiotherapy; Complications | NA | Status: RECRUITING